4//SEC Filing
Ray Amrit 4
Accession 0000950170-25-074661
CIK 0001515673other
Filed
May 18, 8:00 PM ET
Accepted
May 19, 6:31 PM ET
Size
6.8 KB
Accession
0000950170-25-074661
Insider Transaction Report
Form 4
Ray Amrit
Director
Transactions
- Award
Common Stock
2025-05-15+5,740→ 23,365 total - Award
Stock Option (Right to Buy)
2025-05-15+10,787→ 10,787 totalExercise: $34.84Exp: 2035-05-15→ Common Stock (10,787 underlying)
Footnotes (2)
- [F1]Award of Restricted Stock Units ("RSUs") under the Company's 2023 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) May 15, 2026.
- [F2]The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) May 15, 2026.
Documents
Issuer
Ultragenyx Pharmaceutical Inc.
CIK 0001515673
Entity typeother
Related Parties
1- filerCIK 0001924797
Filing Metadata
- Form type
- 4
- Filed
- May 18, 8:00 PM ET
- Accepted
- May 19, 6:31 PM ET
- Size
- 6.8 KB